Mirae Asset Global Etfs Holdings Ltd. Ardelyx, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Ardelyx, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 147,094 shares of ARDX stock, worth $776,656. This represents 0.0% of its overall portfolio holdings.
Number of Shares
147,094
Previous 159,061
7.52%
Holding current value
$776,656
Previous $780,000
26.15%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ARDX
# of Institutions
222Shares Held
167MCall Options Held
517KPut Options Held
1.61M-
Black Rock Inc. New York, NY17.6MShares$92.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$84.6 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X015.1MShares$79.5 Million0.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny11.7MShares$61.6 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C311.5MShares$60.5 Million0.06% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $816M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...